Federal contract award
75F40125P00018
ORA ORS LABORATORY THIRD PARTY LABORATORY ACCREDITATION SERVICES FOR ISO 17025
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 813920 — Professional Organizations |
| PSC | R420 — Certifications and Accreditations for products and institutions other than educational institutions |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $104.4K |
| Current contract value | $104.4K |
| Potential contract value / ceiling | $249.2K |
| Start date | Dec 18, 2024 |
| Current end date | Dec 31, 2026 |
| Potential end date | Dec 31, 2029 |
| Latest award activity | Jul 31, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 31, 2026 | P00002 | $0 | ORA ORS LABORATORY THIRD PARTY LABORATORY ACCREDITATION SERVICES FOR ISO 17025 |
| Dec 23, 2025 | P00001 | $64.0K | ORA ORS LABORATORY THIRD PARTY LABORATORY ACCREDITATION SERVICES FOR ISO 17025 |
| Dec 18, 2024 | 0 | $40.4K | ORA ORS LABORATORY THIRD PARTY LABORATORY ACCREDITATION SERVICES FOR ISO 17025 |
Estimated positioning window
Dec 31, 2028 – Jun 30, 2029
40/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 40/100. Available recorded signals: 35 points.
- Contract end 2029-12-31 (1156 days from calculation)
- +5 points
- 2 historical awards in this buyer and category group
- +10 points
- 3 recorded award transactions
- +5 points
- Latest award action: 2026-07-31
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Amanda Edger | Contact | amanda.edger@fda.hhs.gov | Source | Nov 20, 2024 |
| James Jenrette | Contact | james.jenretteiii@fda.hhs.gov 3018377549 | Source | Nov 20, 2024 |
| Amanda Edger | Contact | amanda.edger@fda.hhs.gov | Source | Nov 20, 2024 |
| James Jenrette | Contact | james.jenretteiii@fda.hhs.gov 3018377549 | Source | Nov 20, 2024 |
| Amanda Edger | Contact | amanda.edger@fda.hhs.gov | Source | Nov 20, 2024 |
| James Jenrette | Contact | james.jenretteiii@fda.hhs.gov 3018377549 | Source | Nov 20, 2024 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.